U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288203) titled 'A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma' on Dec. 09.
Brief Summary: This is a Phase 2, multicenter, open-label study of lifileucel (tumor-infiltrating lymphocytes [TIL]) in participants with previously treated advanced melanoma
Study Start Date: Nov. 28
Study Type: INTERVENTIONAL
Condition:
Melanoma (Skin Cancer)
Unresectable Melanoma
Metastatic Melanoma
Intervention:
BIOLOGICAL: Lifileucel
A tumor sample is resected from each patient for lifileucel manufacturing. Patients will first receive the preparative non-myeloablative lymphodepletion (NMA-LD) regimen. They will then recei...